87 related articles for article (PubMed ID: 16929516)
21. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
22. Cyclin e expression and prognosis in breast cancer patients: a meta-analysis of published studies.
Wang L; Shao ZM
Cancer Invest; 2006 Oct; 24(6):581-7. PubMed ID: 16982462
[TBL] [Abstract][Full Text] [Related]
23. Luteolin sensitises drug-resistant human breast cancer cells to tamoxifen via the inhibition of cyclin E2 expression.
Tu SH; Ho CT; Liu MF; Huang CS; Chang HW; Chang CH; Wu CH; Ho YS
Food Chem; 2013 Nov; 141(2):1553-61. PubMed ID: 23790951
[TBL] [Abstract][Full Text] [Related]
24. A new proteinase 3 substrate with improved selectivity over human neutrophil elastase.
Popow-Stellmaszyk J; Wysocka M; Lesner A; Korkmaz B; Rolka K
Anal Biochem; 2013 Nov; 442(1):75-82. PubMed ID: 23911525
[TBL] [Abstract][Full Text] [Related]
25. Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
Kok M; Linn SC; Van Laar RK; Jansen MP; van den Berg TM; Delahaye LJ; Glas AM; Peterse JL; Hauptmann M; Foekens JA; Klijn JG; Wessels LF; Van't Veer LJ; Berns EM
Breast Cancer Res Treat; 2009 Jan; 113(2):275-83. PubMed ID: 18311582
[TBL] [Abstract][Full Text] [Related]
26. Differences in the substrate binding sites of murine and human proteinase 3 and neutrophil elastase.
Hajjar E; Korkmaz B; Reuter N
FEBS Lett; 2007 Dec; 581(29):5685-90. PubMed ID: 18023421
[TBL] [Abstract][Full Text] [Related]
27. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.
Girault I; Tozlu S; Lidereau R; Bièche I
Clin Cancer Res; 2003 Oct; 9(12):4415-22. PubMed ID: 14555514
[TBL] [Abstract][Full Text] [Related]
28. Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time.
Span PN; Waanders E; Manders P; Heuvel JJ; Foekens JA; Watson MA; Beex LV; Sweep FC
J Clin Oncol; 2004 Feb; 22(4):691-8. PubMed ID: 14966093
[TBL] [Abstract][Full Text] [Related]
29. ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer.
Zhang Z; Yamashita H; Toyama T; Sugiura H; Ando Y; Mita K; Hamaguchi M; Kawaguchi M; Miura Y; Iwase H
Clin Cancer Res; 2005 Jan; 11(1):193-8. PubMed ID: 15671546
[TBL] [Abstract][Full Text] [Related]
30. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate.
Epinette C; Croix C; Jaquillard L; Marchand-Adam S; Kellenberger C; Lalmanach G; Cadene M; Viaud-Massuard MC; Gauthier F; Korkmaz B
Biochem Pharmacol; 2012 Mar; 83(6):788-96. PubMed ID: 22209715
[TBL] [Abstract][Full Text] [Related]
31. Proteinase 3 activity in sputum from subjects with alpha-1-antitrypsin deficiency and COPD.
Sinden NJ; Stockley RA
Eur Respir J; 2013 May; 41(5):1042-50. PubMed ID: 22936713
[TBL] [Abstract][Full Text] [Related]
32. Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer.
Nakayama N; Nakayama K; Shamima Y; Ishikawa M; Katagiri A; Iida K; Miyazaki K
Cancer; 2010 Jun; 116(11):2621-34. PubMed ID: 20336784
[TBL] [Abstract][Full Text] [Related]
33. The role of neutrophil elastase in elastin metabolism of pelvic tissues from women with stress urinary incontinence.
Chen B; Wen Y; Yu X; Polan ML
Neurourol Urodyn; 2007; 26(2):274-9. PubMed ID: 17089373
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer.
Kenny FS; Hui R; Musgrove EA; Gee JM; Blamey RW; Nicholson RI; Sutherland RL; Robertson JF
Clin Cancer Res; 1999 Aug; 5(8):2069-76. PubMed ID: 10473088
[TBL] [Abstract][Full Text] [Related]
35. Proteolytic processing of cut homeobox 1 by neutrophil elastase in the MV4;11 myeloid leukemia cell line.
Goulet B; Markovic Y; Leduy L; Nepveu A
Mol Cancer Res; 2008 Apr; 6(4):644-53. PubMed ID: 18403643
[TBL] [Abstract][Full Text] [Related]
36. How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study.
Sieuwerts AM; Meijer-van Gelder ME; Timmermans M; Trapman AM; Garcia RR; Arnold M; Goedheer AJ; Portengen H; Klijn JG; Foekens JA
Clin Cancer Res; 2005 Oct; 11(20):7311-21. PubMed ID: 16243802
[TBL] [Abstract][Full Text] [Related]
37. Cell cycle dysregulation influences survival in high risk breast cancer patients.
Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C
Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474
[TBL] [Abstract][Full Text] [Related]
38. Detection of low molecular weight derivatives of cyclin E1 is a function of cyclin E1 protein levels in breast cancer.
Spruck C; Sun D; Fiegl H; Marth C; Mueller-Holzner E; Goebel G; Widschwendter M; Reed SI
Cancer Res; 2006 Jul; 66(14):7355-60. PubMed ID: 16849587
[TBL] [Abstract][Full Text] [Related]
39. Target protein interactions of indole-3-carbinol and the highly potent derivative 1-benzyl-I3C with the C-terminal domain of human elastase uncouples cell cycle arrest from apoptotic signaling.
Aronchik I; Chen T; Durkin KA; Horwitz MS; Preobrazhenskaya MN; Bjeldanes LF; Firestone GL
Mol Carcinog; 2012 Nov; 51(11):881-94. PubMed ID: 22012859
[TBL] [Abstract][Full Text] [Related]
40. Differences between human proteinase 3 and neutrophil elastase and their murine homologues are relevant for murine model experiments.
Wiesner O; Litwiller RD; Hummel AM; Viss MA; McDonald CJ; Jenne DE; Fass DN; Specks U
FEBS Lett; 2005 Oct; 579(24):5305-12. PubMed ID: 16182289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]